Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 3 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 20 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 6 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A0A3S7WYS5
Term | Name | Level | Count |
---|---|---|---|
GO:0006084 | acetyl-CoA metabolic process | 5 | 2 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 2 |
GO:0006163 | purine nucleotide metabolic process | 5 | 2 |
GO:0006629 | lipid metabolic process | 3 | 2 |
GO:0006637 | acyl-CoA metabolic process | 4 | 2 |
GO:0006644 | phospholipid metabolic process | 4 | 2 |
GO:0006720 | isoprenoid metabolic process | 4 | 2 |
GO:0006721 | terpenoid metabolic process | 5 | 2 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 2 |
GO:0006753 | nucleoside phosphate metabolic process | 4 | 2 |
GO:0006790 | sulfur compound metabolic process | 3 | 2 |
GO:0006793 | phosphorus metabolic process | 3 | 2 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0008299 | isoprenoid biosynthetic process | 4 | 2 |
GO:0008610 | lipid biosynthetic process | 4 | 2 |
GO:0008654 | phospholipid biosynthetic process | 5 | 2 |
GO:0009058 | biosynthetic process | 2 | 2 |
GO:0009117 | nucleotide metabolic process | 5 | 2 |
GO:0009150 | purine ribonucleotide metabolic process | 6 | 2 |
GO:0009259 | ribonucleotide metabolic process | 5 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0010142 | farnesyl diphosphate biosynthetic process, mevalonate pathway | 6 | 2 |
GO:0016114 | terpenoid biosynthetic process | 5 | 2 |
GO:0019637 | organophosphate metabolic process | 3 | 2 |
GO:0019693 | ribose phosphate metabolic process | 4 | 2 |
GO:0033865 | nucleoside bisphosphate metabolic process | 5 | 2 |
GO:0033875 | ribonucleoside bisphosphate metabolic process | 6 | 2 |
GO:0034032 | purine nucleoside bisphosphate metabolic process | 5 | 2 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 2 |
GO:0035383 | thioester metabolic process | 3 | 2 |
GO:0043603 | amide metabolic process | 3 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0044249 | cellular biosynthetic process | 3 | 2 |
GO:0044255 | cellular lipid metabolic process | 3 | 2 |
GO:0044281 | small molecule metabolic process | 2 | 2 |
GO:0045337 | farnesyl diphosphate biosynthetic process | 6 | 2 |
GO:0045338 | farnesyl diphosphate metabolic process | 5 | 2 |
GO:0046483 | heterocycle metabolic process | 3 | 2 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 3 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:0072521 | purine-containing compound metabolic process | 4 | 2 |
GO:0090407 | organophosphate biosynthetic process | 4 | 2 |
GO:1901135 | carbohydrate derivative metabolic process | 3 | 2 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 2 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 2 |
GO:1901576 | organic substance biosynthetic process | 3 | 2 |
GO:1902767 | isoprenoid biosynthetic process via mevalonate | 5 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 11 |
GO:0004421 | hydroxymethylglutaryl-CoA synthase activity | 5 | 4 |
GO:0016740 | transferase activity | 2 | 11 |
GO:0016746 | acyltransferase activity | 3 | 11 |
GO:0046912 | acyltransferase activity, acyl groups converted into alkyl on transfer | 4 | 4 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 88 | 92 | PF00656 | 0.514 |
CLV_NRD_NRD_1 | 205 | 207 | PF00675 | 0.486 |
CLV_NRD_NRD_1 | 210 | 212 | PF00675 | 0.499 |
CLV_NRD_NRD_1 | 354 | 356 | PF00675 | 0.528 |
CLV_NRD_NRD_1 | 399 | 401 | PF00675 | 0.538 |
CLV_NRD_NRD_1 | 471 | 473 | PF00675 | 0.489 |
CLV_PCSK_KEX2_1 | 210 | 212 | PF00082 | 0.488 |
CLV_PCSK_KEX2_1 | 471 | 473 | PF00082 | 0.466 |
CLV_PCSK_PC7_1 | 206 | 212 | PF00082 | 0.461 |
CLV_PCSK_SKI1_1 | 341 | 345 | PF00082 | 0.483 |
CLV_PCSK_SKI1_1 | 349 | 353 | PF00082 | 0.438 |
DOC_CYCLIN_yCln2_LP_2 | 444 | 450 | PF00134 | 0.475 |
DOC_MAPK_gen_1 | 147 | 154 | PF00069 | 0.529 |
DOC_MAPK_gen_1 | 206 | 216 | PF00069 | 0.608 |
DOC_MAPK_gen_1 | 355 | 363 | PF00069 | 0.501 |
DOC_MAPK_gen_1 | 469 | 476 | PF00069 | 0.545 |
DOC_MAPK_MEF2A_6 | 147 | 154 | PF00069 | 0.529 |
DOC_PP1_RVXF_1 | 76 | 82 | PF00149 | 0.515 |
DOC_PP2B_LxvP_1 | 426 | 429 | PF13499 | 0.441 |
DOC_PP4_FxxP_1 | 205 | 208 | PF00568 | 0.451 |
DOC_PP4_FxxP_1 | 234 | 237 | PF00568 | 0.459 |
DOC_PP4_FxxP_1 | 274 | 277 | PF00568 | 0.386 |
DOC_USP7_MATH_1 | 10 | 14 | PF00917 | 0.427 |
DOC_USP7_MATH_1 | 113 | 117 | PF00917 | 0.513 |
DOC_USP7_MATH_1 | 134 | 138 | PF00917 | 0.545 |
DOC_USP7_MATH_1 | 153 | 157 | PF00917 | 0.554 |
DOC_USP7_MATH_1 | 162 | 166 | PF00917 | 0.488 |
DOC_USP7_MATH_1 | 419 | 423 | PF00917 | 0.514 |
DOC_USP7_UBL2_3 | 352 | 356 | PF12436 | 0.530 |
DOC_USP7_UBL2_3 | 469 | 473 | PF12436 | 0.553 |
DOC_WW_Pin1_4 | 258 | 263 | PF00397 | 0.512 |
DOC_WW_Pin1_4 | 369 | 374 | PF00397 | 0.495 |
LIG_14-3-3_CanoR_1 | 296 | 305 | PF00244 | 0.426 |
LIG_14-3-3_CanoR_1 | 3 | 9 | PF00244 | 0.522 |
LIG_BIR_III_2 | 342 | 346 | PF00653 | 0.579 |
LIG_BIR_III_4 | 143 | 147 | PF00653 | 0.474 |
LIG_deltaCOP1_diTrp_1 | 27 | 32 | PF00928 | 0.530 |
LIG_FAT_LD_1 | 251 | 259 | PF03623 | 0.438 |
LIG_FHA_1 | 137 | 143 | PF00498 | 0.595 |
LIG_FHA_1 | 174 | 180 | PF00498 | 0.576 |
LIG_FHA_1 | 246 | 252 | PF00498 | 0.451 |
LIG_FHA_1 | 345 | 351 | PF00498 | 0.424 |
LIG_FHA_1 | 381 | 387 | PF00498 | 0.364 |
LIG_FHA_1 | 397 | 403 | PF00498 | 0.437 |
LIG_FHA_2 | 296 | 302 | PF00498 | 0.477 |
LIG_FHA_2 | 458 | 464 | PF00498 | 0.504 |
LIG_LIR_Apic_2 | 198 | 203 | PF02991 | 0.481 |
LIG_LIR_Apic_2 | 204 | 208 | PF02991 | 0.446 |
LIG_LIR_Gen_1 | 235 | 243 | PF02991 | 0.423 |
LIG_LIR_Gen_1 | 357 | 368 | PF02991 | 0.421 |
LIG_LIR_Gen_1 | 36 | 44 | PF02991 | 0.595 |
LIG_LIR_Gen_1 | 486 | 497 | PF02991 | 0.429 |
LIG_LIR_Nem_3 | 230 | 234 | PF02991 | 0.427 |
LIG_LIR_Nem_3 | 235 | 241 | PF02991 | 0.432 |
LIG_LIR_Nem_3 | 357 | 363 | PF02991 | 0.416 |
LIG_LIR_Nem_3 | 36 | 40 | PF02991 | 0.511 |
LIG_LIR_Nem_3 | 486 | 492 | PF02991 | 0.442 |
LIG_LIR_Nem_3 | 495 | 500 | PF02991 | 0.392 |
LIG_PTB_Apo_2 | 324 | 331 | PF02174 | 0.465 |
LIG_PTB_Phospho_1 | 324 | 330 | PF10480 | 0.466 |
LIG_REV1ctd_RIR_1 | 271 | 276 | PF16727 | 0.376 |
LIG_SH2_CRK | 238 | 242 | PF00017 | 0.484 |
LIG_SH2_CRK | 497 | 501 | PF00017 | 0.423 |
LIG_SH2_NCK_1 | 266 | 270 | PF00017 | 0.435 |
LIG_SH2_NCK_1 | 58 | 62 | PF00017 | 0.514 |
LIG_SH2_SRC | 18 | 21 | PF00017 | 0.544 |
LIG_SH2_SRC | 266 | 269 | PF00017 | 0.552 |
LIG_SH2_STAP1 | 238 | 242 | PF00017 | 0.406 |
LIG_SH2_STAP1 | 382 | 386 | PF00017 | 0.367 |
LIG_SH2_STAP1 | 398 | 402 | PF00017 | 0.550 |
LIG_SH2_STAP1 | 58 | 62 | PF00017 | 0.514 |
LIG_SH2_STAT3 | 330 | 333 | PF00017 | 0.583 |
LIG_SH2_STAT5 | 219 | 222 | PF00017 | 0.621 |
LIG_SH2_STAT5 | 305 | 308 | PF00017 | 0.468 |
LIG_SH2_STAT5 | 330 | 333 | PF00017 | 0.468 |
LIG_SH2_STAT5 | 382 | 385 | PF00017 | 0.363 |
LIG_SH2_STAT5 | 398 | 401 | PF00017 | 0.453 |
LIG_SH2_STAT5 | 58 | 61 | PF00017 | 0.514 |
LIG_SH3_3 | 14 | 20 | PF00018 | 0.514 |
LIG_SH3_3 | 421 | 427 | PF00018 | 0.391 |
LIG_SUMO_SIM_par_1 | 245 | 252 | PF11976 | 0.535 |
LIG_TRAF2_1 | 298 | 301 | PF00917 | 0.520 |
MOD_CDC14_SPxK_1 | 261 | 264 | PF00782 | 0.503 |
MOD_CDK_SPxK_1 | 258 | 264 | PF00069 | 0.513 |
MOD_CK1_1 | 369 | 375 | PF00069 | 0.422 |
MOD_CK1_1 | 90 | 96 | PF00069 | 0.362 |
MOD_CK2_1 | 162 | 168 | PF00069 | 0.382 |
MOD_CK2_1 | 295 | 301 | PF00069 | 0.454 |
MOD_CK2_1 | 333 | 339 | PF00069 | 0.507 |
MOD_CK2_1 | 457 | 463 | PF00069 | 0.565 |
MOD_CMANNOS | 29 | 32 | PF00535 | 0.348 |
MOD_GlcNHglycan | 12 | 15 | PF01048 | 0.362 |
MOD_GlcNHglycan | 136 | 139 | PF01048 | 0.417 |
MOD_GlcNHglycan | 193 | 196 | PF01048 | 0.431 |
MOD_GlcNHglycan | 222 | 225 | PF01048 | 0.519 |
MOD_GlcNHglycan | 234 | 237 | PF01048 | 0.403 |
MOD_GlcNHglycan | 335 | 338 | PF01048 | 0.534 |
MOD_GlcNHglycan | 415 | 418 | PF01048 | 0.411 |
MOD_GlcNHglycan | 91 | 95 | PF01048 | 0.348 |
MOD_GSK3_1 | 163 | 170 | PF00069 | 0.392 |
MOD_GSK3_1 | 191 | 198 | PF00069 | 0.458 |
MOD_GSK3_1 | 232 | 239 | PF00069 | 0.436 |
MOD_GSK3_1 | 413 | 420 | PF00069 | 0.393 |
MOD_GSK3_1 | 44 | 51 | PF00069 | 0.382 |
MOD_GSK3_1 | 83 | 90 | PF00069 | 0.348 |
MOD_N-GLC_1 | 438 | 443 | PF02516 | 0.457 |
MOD_N-GLC_2 | 4 | 6 | PF02516 | 0.593 |
MOD_NEK2_1 | 191 | 196 | PF00069 | 0.511 |
MOD_NEK2_1 | 2 | 7 | PF00069 | 0.573 |
MOD_NEK2_1 | 402 | 407 | PF00069 | 0.493 |
MOD_NEK2_1 | 48 | 53 | PF00069 | 0.406 |
MOD_PIKK_1 | 167 | 173 | PF00454 | 0.392 |
MOD_PK_1 | 39 | 45 | PF00069 | 0.391 |
MOD_PKA_1 | 366 | 372 | PF00069 | 0.518 |
MOD_PKA_2 | 2 | 8 | PF00069 | 0.539 |
MOD_PKA_2 | 295 | 301 | PF00069 | 0.434 |
MOD_PKA_2 | 48 | 54 | PF00069 | 0.427 |
MOD_Plk_1 | 245 | 251 | PF00069 | 0.443 |
MOD_Plk_1 | 267 | 273 | PF00069 | 0.525 |
MOD_Plk_1 | 417 | 423 | PF00069 | 0.522 |
MOD_Plk_4 | 237 | 243 | PF00069 | 0.414 |
MOD_Plk_4 | 284 | 290 | PF00069 | 0.379 |
MOD_Plk_4 | 39 | 45 | PF00069 | 0.391 |
MOD_ProDKin_1 | 258 | 264 | PF00069 | 0.516 |
MOD_ProDKin_1 | 369 | 375 | PF00069 | 0.492 |
MOD_SUMO_rev_2 | 120 | 127 | PF00179 | 0.348 |
MOD_SUMO_rev_2 | 181 | 187 | PF00179 | 0.563 |
MOD_SUMO_rev_2 | 299 | 304 | PF00179 | 0.575 |
MOD_SUMO_rev_2 | 335 | 343 | PF00179 | 0.523 |
MOD_SUMO_rev_2 | 362 | 369 | PF00179 | 0.556 |
TRG_DiLeu_BaLyEn_6 | 64 | 69 | PF01217 | 0.367 |
TRG_ENDOCYTIC_2 | 238 | 241 | PF00928 | 0.411 |
TRG_ENDOCYTIC_2 | 266 | 269 | PF00928 | 0.465 |
TRG_ENDOCYTIC_2 | 278 | 281 | PF00928 | 0.448 |
TRG_ENDOCYTIC_2 | 455 | 458 | PF00928 | 0.428 |
TRG_ENDOCYTIC_2 | 497 | 500 | PF00928 | 0.392 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PBZ7 | Leptomonas seymouri | 87% | 100% |
A0A0S4IYM8 | Bodo saltans | 66% | 100% |
A0A1D8PTW6 | Candida albicans (strain SC5314 / ATCC MYA-2876) | 25% | 100% |
A0A1X0NXJ5 | Trypanosomatidae | 69% | 100% |
A0A6S5ZZ88 | Fusarium sp. | 25% | 100% |
A4HDS2 | Leishmania braziliensis | 94% | 100% |
A4I120 | Leishmania infantum | 100% | 100% |
C9ZW88 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 67% | 95% |
D4GWR6 | Haloferax volcanii (strain ATCC 29605 / DSM 3757 / JCM 8879 / NBRC 14742 / NCIMB 2012 / VKM B-1768 / DS2) | 24% | 100% |
E9AX57 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 98% | 100% |
F9X3D9 | Zymoseptoria tritici (strain CBS 115943 / IPO323) | 26% | 100% |
I1RY35 | Gibberella zeae (strain ATCC MYA-4620 / CBS 123657 / FGSC 9075 / NRRL 31084 / PH-1) | 25% | 100% |
K7PL94 | Ganoderma lucidum | 25% | 100% |
O02734 | Sus scrofa | 22% | 99% |
P23228 | Gallus gallus | 23% | 96% |
P54839 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 23% | 100% |
P54870 | Blattella germanica | 24% | 100% |
P54873 | Arabidopsis thaliana | 26% | 100% |
P54874 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 25% | 100% |
P54961 | Blattella germanica | 25% | 100% |
Q01581 | Homo sapiens | 22% | 96% |
Q4P3F1 | Ustilago maydis (strain 521 / FGSC 9021) | 26% | 100% |
Q4QAB9 | Leishmania major | 99% | 100% |
Q4WBQ3 | Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) | 24% | 100% |
Q5R7Z9 | Pongo abelii | 22% | 96% |
Q9FD71 | Enterococcus faecalis | 24% | 100% |
V5B9Q1 | Trypanosoma cruzi | 68% | 100% |
V5XYR2 | Alternaria alternata | 26% | 100% |